Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis-Reference-Cited by-同舟云学术

Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis

Published:2016-12 Issue:3 Volume:84 Page:272-281
ISSN:0923-1811
Container-title:Journal of Dermatological Science
language:en
Short-container-title:Journal of Dermatological Science

Author:

Fujimoto Manabu,Murakami Akihiro,Kurei Shunsuke,Okiyama Naoko,Kawakami Atsushi,Mishima Michiaki,Sato Shinji,Seishima Mariko,Suda Takafumi,Mimori Tsuneyo,Takehara Kazuhiko,Kuwana Masataka

Publisher

Elsevier BV

Subject

Dermatology,Molecular Biology,Biochemistry

Reference41 articles.

1. Pathogenesis, classification and treatment of inflammatory myopathies;Zong;Nat. Rev. Rheumatol.,2011

2. Myositis specific and associated autoantibodies in the diagnosis and management of juvenile and adult idiopathic inflammatory myopathies;Tansley;Curr. Rheumatol. Rep.,2014

3. Myositis autoantibodies;Casciola-Rosen;Curr. Opin. Rheumatol.,2012

4. Myositis-specific autoantibodies: an important tool to support diagnosis of myositis;Betteridge;J. Intern. Med.,2016

5. A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy;Satoh;Clin. Rev. Allergy Immunol.,2016

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case of Amyloid Myopathy Mimicking Anti-Mi-2 Antibody-Positive Myositis;Journal of General Internal Medicine;2024-09-09

2. Advances in Juvenile Dermatomyositis: Pathophysiology, Diagnosis, Treatment and Interstitial Lung Diseases—A Narrative Review;Children;2024-08-27

3. Autoantibody testing in myositis: an update;Current Opinion in Rheumatology;2024-08-20

4. Quid de la détection des anticorps anti-TIF1γ dans les dermatomyosites ?;Revue Francophone des Laboratoires;2024-05

5. Autoantibodies Recognizing Specificity Protein 4 Co‐occur With Anti–Transcription Intermediary Factor 1 and Are Associated With Distinct Clinical Features and Immunogenetic Risk Factors in Juvenile Myositis;Arthritis & Rheumatology;2023-07-19